FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas

BACKGROUND: Molecular profiling of gliomas is vital to ensure diagnostic accuracy, inform prognosis, and identify clinical trial options for primary and recurrent tumors. This study aimed to determine the accuracy of reporting the whole arm 1p19q codeletion status from the FoundationOne platform. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharaf, Radwa, Pavlick, Dean C, Frampton, Garrett M, Cooper, Maureen, Jenkins, Jacqueline, Danziger, Natalie, Haberberger, James, Alexander, Brian M, Cloughesy, Timothy, Yong, William H, Liau, Linda M, Nghiemphu, Phioanh L, Ji, Matthew, Lai, Albert, Ramkissoon, Shakti H, Albacker, Lee A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986056/
https://www.ncbi.nlm.nih.gov/pubmed/33778493
http://dx.doi.org/10.1093/noajnl/vdab017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986056/
https://www.ncbi.nlm.nih.gov/pubmed/33778493
http://dx.doi.org/10.1093/noajnl/vdab017

Ejemplares similares